Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
Exp Mol Pathol
; 95(3): 276-87, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-24045095
Palavras-chave
Aberrant DNA hypermethylation; Basal-like breast cancer; Claudin-low breast cancer; DNA methyltransferase; DNMT; EMT; ER; HER2; PR; TIC; TMI; Triple-negative breast cancer; epithelial-to-mesenchymal transition; estrogen receptor; gene encoding the epidermal growth factor receptor 2; miR; microRNA; progesterone receptor; total methylation index; tumor initiating cell
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Mama
/
Biomarcadores Tumorais
/
Regiões Promotoras Genéticas
/
Metilação de DNA
/
Epigenômica
/
Neoplasias de Mama Triplo Negativas
/
Recidiva Local de Neoplasia
Tipo de estudo:
Prognostic_studies
Limite:
Female
/
Humans
Idioma:
En
Revista:
Exp Mol Pathol
Ano de publicação:
2013
Tipo de documento:
Article